Table 4. Patients’ characteristics.
| Variables | n | % |
|---|---|---|
| Sex | ||
| Male | 40 | 71.4 |
| Female | 16 | 28.6 |
| Age (years) | ||
| Median | 69 | |
| Range | 21–80 | |
| ECOG PS | ||
| 0 | 21 | 37.5 |
| 1 | 35 | 62.5 |
| Hepatitis | ||
| None | 6 | 10.7 |
| HBV | 38 | 67.9 |
| HCV | 5 | 8.9 |
| Alcoholic | 7 | 12.5 |
| Liver cirrhosis | ||
| No | 16 | 28.6 |
| Yes | 40 | 71.4 |
| PVTT | ||
| No | 25 | 44.6 |
| Yes | 31 | 55.4 |
| AFP (IU/mL) | ||
| < 400 | 40 | 71.4 |
| ≥ 400 | 16 | 28.6 |
| CP class before radiotherapy | ||
| A | 47 | 83.9 |
| B | 9 | 16.1 |
| AJCC stage | ||
| II | 8 | 14.3 |
| III | 43 | 76.8 |
| IVA | 5 | 8.9 |
| Previous treatment | ||
| None | 6 | 12.5 |
| TACE | 49 | 87.5 |
| RFA | 7 | 12.5 |
| PEI | 4 | 7.1 |
| Chemotherapy | 12 | 21.4 |
Abbreviations: ECOG PS, Eastern Cooperative Oncology Group performance status; HBV, hepatitis B virus; HCV, hepatitis C virus; PVTT, portal vein tumor thrombosis; AFP, alpha-fetoprotein; CP class, Child-Pugh class; AJCC, American Joint Committee on Cancer; TACE, transarterial chemoembolization; RFA, radiofrequency ablation; PEI, percutaneous ethanol injection.